Cis-platinum induces immunity evasion demonstrated by PD-L1 expression in bladder cancer cells

Cis-platinum induces immunity evasion demonstrated by PD-L1 expression in bladder cancer cells

Bibliographic Details
Main Authors:	T. Hwang, P. Chen, T. Tsai, S. Yang, H. Chen, Y. Lin, K. Chou, J. Lin
Format:	Article
Language:	English
Published:	Elsevier 2020-07-01
Series:	European Urology Open Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666168320326148

Similar Items

The role of cancer cell-expressed PD-1 in tumorigenesis and tumor immune evasion
by: Kleffel, Sonja Beate
Published: (2018)

A Tumor-Specific Super-Enhancer Drives Immune Evasion by Guiding Synchronous Expression of PD-L1 and PD-L2
by: Yuanpei Xu, et al.
Published: (2020-07-01)

A Tumor-Specific Super-Enhancer Drives Immune Evasion by Guiding Synchronous Expression of PD-L1 and PD-L2
by: Yuanpei Xu, et al.
Published: (2019-12-01)

Targeting the PD-1/PD-L1 Cancer Immune Evasion Axis: Challenges and Emerging Strategies
Published: (2020)

Increased Nuclear Transporter KPNA2 Contributes to Tumor Immune Evasion by Enhancing PD-L1 Expression in PDAC
by: Kai-Xia Zhou, et al.
Published: (2021-01-01)

Regulation of PD-L1: Emerging Routes for Targeting Tumor Immune Evasion
by: Yiting Wang, et al.
Published: (2018-05-01)

cis-Dichloridobis(triisopropoxyphosphine)platinum(II)
by: Alexandra M. Z. Slawin, et al.
Published: (2009-11-01)

cis-Dimethylbis(triphenylarsine)platinum(II)
by: Anwar Abo-Amer
Published: (2010-02-01)

Studies on the gastrointestinal toxicity of Cis-platinum
by: Allan, Simon G.
Published: (1985)

Editorial: Targeting the PD-1/PD-L1 Cancer Immune Evasion Axis: Challenges and Emerging Strategies
by: Yiting Wang, et al.
Published: (2020-09-01)

Hantavirus-Driven PD-L1/PD-L2 Upregulation: An Imperfect Viral Immune Evasion Mechanism
by: Martin J. Raftery, et al.
Published: (2018-12-01)

The folate cycle enzyme MTHFD2 induces cancer immune evasion through PD-L1 up-regulation
by: Man Shang, et al.
Published: (2021-03-01)

Overcoming Immune Evasion in Melanoma
by: Kevinn Eddy, et al.
Published: (2020-11-01)

Current Understanding of the Mechanisms Underlying Immune Evasion From PD-1/PD-L1 Immune Checkpoint Blockade in Head and Neck Cancer
by: Victor C. Kok, et al.
Published: (2020-02-01)

Pd seed induced growth of sea urchin like platinum nanowires
by: Wei-han Chen, et al.
Published: (2010)

Leishmania donovani: Immune response and immune evasion with emphasis on PD-1/PDL-1 pathway and role of autophagy
by: Samar Habib, et al.
Published: (2021-01-01)

STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion
by: Jung-Mao Hsu, et al.
Published: (2018-05-01)

GM-CSF mediates immune evasion via upregulation of PD-L1 expression in extranodal natural killer/T cell lymphoma
by: Qi-xiang Rong, et al.
Published: (2021-05-01)

Immune evasion in glioma
by: Close, Helen Judith
Published: (2016)

Mechanism of immune evasion in breast cancer
by: Wang M, et al.
Published: (2017-03-01)

Innate Immunity and Immune Evasion by Enterovirus 71
by: Prabuddha S. Pathinayake, et al.
Published: (2015-12-01)

CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis
by: Hui Yang, et al.
Published: (2020-02-01)

Understanding Immune Evasion and Therapeutic Targeting Associated with PD-1/PD-L1 Pathway in Diffuse Large B-cell Lymphoma
by: Moo-Kon Song, et al.
Published: (2019-03-01)

An investigation into the nephrotoxicity of Cisplatin (cis-dichloradiammine platinum II)
by: Daley-Yates, P. T.
Published: (1981)

Studies on the Nephrotoxicity of Cis-Diammine-Dichloro-Platinum Â²+
by: Ahmed, S. M.
Published: (1976)

Glutaminolysis Mediated by MALT1 Protease Activity Facilitates PD-L1 Expression on ABC-DLBCL Cells and Contributes to Their Immune Evasion
by: Xichun Xia, et al.
Published: (2018-12-01)

Tumor-Intrinsic PD-L1 Signaling in Cancer Initiation, Development and Treatment: Beyond Immune Evasion
by: Peixin Dong, et al.
Published: (2018-09-01)

Circulating PD‐1 (+) cells may participate in immune evasion in peripheral T‐cell lymphoma and chidamide enhance antitumor activity of PD‐1 (+) cells
by: Wei Zhang, et al.
Published: (2019-05-01)

Targeting the PD-1/PD-L1 Immune Evasion Axis With DNA Aptamers as a Novel Therapeutic Strategy for the Treatment of Disseminated Cancers
by: Aaron Prodeus, et al.
Published: (2015-01-01)

Platinum and Gold Catalyzed Cyclization of cis-2,4-Diene-1-als and Enynes
by: Chung-Cheng Lin, et al.
Published: (2008)

Crk adaptor protein promotes PD-L1 expression, EMT and immune evasion in a murine model of triple-negative breast cancer
by: Sushil Kumar, et al.
Published: (2018-01-01)

Immune Evasion Strategies of Schistosomes
by: Jacob R. Hambrook, et al.
Published: (2021-02-01)

Immune Evasion Strategies of Glioblastoma
by: Seyed-Mostafa eRazavi, et al.
Published: (2016-03-01)

Filoviral Immune Evasion Mechanisms
by: Christopher F. Basler, et al.
Published: (2011-09-01)

Lymphoma: Immune Evasion Strategies
by: Ranjan Upadhyay, et al.
Published: (2015-04-01)

Viral Induced Protein Aggregation: A Mechanism of Immune Evasion
by: Elena Muscolino, et al.
Published: (2021-09-01)

Synthesis and crystal structures of cis-palladium(II) and cis-platinum(II) complexes containing dipyridyl ligands
by: Noemí Andrade-López, et al.
Published: (2007-08-01)

Crystal and molecular structure of cis-Dichlorobis(triphenylphosphite) Platinum(II)
by: Ali Naghipour, et al.
Published: (2001-08-01)

cis-Bis(2-sulfidopyridine N-oxide)platinum(II)
by: Dieter Schollmeyer, et al.
Published: (2008-02-01)

Kinetic and analytical studies of cis- and trans-diammindichloro platinum (II)
by: Hicks, C. P.
Published: (1982)